This proposal brings together the two largest NIH funded genetic studies focused on the identification of novel genes that influence the risk of PD. These two studies, PROGENI (PI: Tatiana Foroud; R01NS037167) and GenePD (PI: Richard Myers; R01NS036711) have been evaluating and recruiting families with two or more PD affected members for more than 8 years and represent the largest such cohorts world-wide. The combined sample has more than 1,000 PD families. Each study has used rigorous clinical criteria to assess their study participants. Unlike previous genome wide association studies (GWAS) in PD, all the PD cases in this proposal have a positive family history of disease. In the vast majority of these families, the index PD case has at least one sibling with the disease. Thus, the sample is unique for having substantial evidence for a genetic contribution to disease. The control group for this study consists of samples previously collected and maintained by the NINDS Repository. Genome-wide, single nucleotide polymorphism (SNP) genotyping services were provided by <a href="http://www.cidr.jhmi.edu/">the Center for Inherited Disease Research (CIDR)</a>. Data analyses will focus on the identification of SNPs associated with PD susceptibility and the age of onset of disease.

CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)

Parkinson Disease study with SNP Genotypes (Array) data on dbGaP (1,991 participants)

CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)

Description

Applying For Access

Summary